Sam Lerman

1.5k citations
14 papers · 1.2k · 2 hit papers · h-index 11

Impact in

    • Pituitary Gland Disorders and Treatments
    • Diabetes Treatment and Management
    • Diabetes Management and Research
    • Hormonal Regulation and Hypertension
  • Nephrology top 5%
    • Chronic Kidney Disease and Diabetes
    • Parathyroid Disorders and Treatments

Papers in

Sam Lerman

13 papers receiving 1.1k citations

Sam Lerman's Hit Papers

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis 2022 · 170 citations
1700+4+9Years since publication100200300

Peers

Sam Lerman
Comparison fields: 5 of 70
  • Endocrinology, Diabetes and Metabolism 656
  • Nephrology 283
  • Behavioral Neuroscience 23
  • Pathology and Forensic Medicine 104
  • Pulmonary and Respiratory Medicine 63
Replace O. Djøseland with:
O. Djøseland Norway
Jane A. Lawson Australia
George Z. Fadda United States
Makoto Ujihara Japan
Björn Sjögren Sweden
W. Marz Germany
W. Schopman Netherlands
Nobuhiro Ayuzawa Japan
Donatella Santoro Italy
Robert Wolfgang Kurz Austria
Sam Lerman relative to O. Djøseland Norway O. Djøseland's profile →
Citations per field
00.5×10×20×30×40×49×
O. Djøseland · 1×
Citations per year

Countries citing papers authored by Sam Lerman

Since Specialization
Citations

This map shows the geographic impact of Sam Lerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Lerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Lerman more than expected).

Fields of papers citing papers by Sam Lerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Lerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Lerman. The network helps show where Sam Lerman may publish in the future.

Co-authors

The 25 scholars most cited alongside Sam Lerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sam Lerman Line = papers co-authored together Sam Lerman links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome
Hit paper breakdown →
2012398
2 2018210
3
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Hit paper breakdown →
2022170
4 1978128
5 2005108
6 202364
7 201451
8 197733
9
in the Dog
197728
10 198314
11 202514
12 20258
13 19803
14 19990

About Sam Lerman

Sam Lerman is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine, Emergency Medicine and Biomedical Engineering, having authored 14 papers that have together received 1.2k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (3 papers), Diabetes Treatment and Management (3 papers), Adrenal Hormones and Disorders (2 papers), Vitamin D Research Studies (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Diabetes Management and Research (2 papers), Mechanical Circulatory Support Devices (1 paper) and Alcohol Consumption and Health Effects (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (656 citations), Nephrology (283 citations), Behavioral Neuroscience (23 citations), Pathology and Forensic Medicine (104 citations) and Pulmonary and Respiratory Medicine (63 citations). Sam Lerman has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Janet M. Canterbury, Eric Reiss, Anthony W. Norman, Helen L. Henry, Alice J. Claflin, Ralph Anthony DeFronzo, William T. Cefalu, Lawrence S. Phillips, Richard M. Bergenstal and John R. Pullman. Their work appears in journals such as Diabetes Care, The Journal of Clinical Endocrinology & Metabolism, Journal of Clinical Investigation, The Lancet and Journal of clinical lipidology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact